Overview
- 3 inspections across 3 sites are on record.
- 6 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2018-07-18.
At a glance
Inspections
3
Sites
3
Observations
6
Career since
May 2017
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Nesher Pharmaceuticals (USA) LLC | 18 Jul 2018 | Human Drugs | On file |
| Catalent Massachusetts, LLC | 18 Jun 2018 | Medical Devices & Rad Health | View 483 → |
| Swiss Pharmaceutical Company Ltd | 12 May 2017 | Human Drugs | On file |
Sites inspected
Nesher Pharmaceuticals (USA) LLCBridgeton, United States1 insp.
Catalent Massachusetts, LLCChelsea, United States1 insp.
Swiss Pharmaceutical Company LtdTai Nan Shi, Taiwan1 insp.
Co-investigators
Investigators who share inspections with this person.
Andrew J Idzior1 shared
Stephen C Smith1 shared
Erik W Koester1 shared
Michele Perry-Williams1 shared
Katherine Szestypalow1 shared
Santos E Camara1 shared
Full investigator report
Get the verbatim findings behind Yaodong Huang's 6 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site